See All Slides - tctmd.com

Slides

Presentation TCT 2012

Case Review 4: How to Deal with Valve Complications

Presenter: Jason Rogers

October 25, 2012

Presentation TCT 2012

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Roxana Mehran

October 25, 2012

Presentation TCT 2012

"Impact of the Presence and Extent of Incomplete Angiographic Revascularization after Percutaneous Coronary Intervention in Acute Coronary Syndromes: The ACUITY Trial."...

Presenter: Gregg Rosner

October 24, 2012

Presentation TCT 2012

Drip, Ship, and Fix or Drip, Ship, and Wait?

Presenter: Christopher Buller

October 24, 2012

Presentation TCT 2012

Phase II and III Clinical Trials: Off and Running!

Presenter: Amit Patel

October 22, 2012

Presentation TVT 2014

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Presenter: Axel Linke

June 06, 2014

Presentation TVT 2014

The Daunting Task of Explaining High TAVR Costs to Practitioners, Hospital Administrators, and Healthcare Systems

Presenter: Larry L. Wood

June 07, 2014

Presentation TVT 2014

Reasons and Results of NO Predilation Before TAVR: How to Improve Outcomes and SIMPLIFY Your Life

Presenter: Mathew Williams

June 07, 2014

Presentation TVT 2014

Yes, Clearly!

Presenter: Olaf Wendler

June 07, 2014

Presentation

Clopidogrel Prescription Filling Delays and Cardiovascular Outcomes in a Pharmacy System Integrating Inpatient and Outpatient Care

Presenter: J.B. Byrd

June 16, 2014

Advertisement

Slides

Case Review 4: How to Deal with Valve Complications

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

"Impact of the Presence and Extent of Incomplete Angiographic Revascularization after Percutaneous Coronary Intervention in Acute Coronary Syndromes: The ACUITY Trial."...

Drip, Ship, and Fix or Drip, Ship, and Wait?

Phase II and III Clinical Trials: Off and Running!

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

The Daunting Task of Explaining High TAVR Costs to Practitioners, Hospital Administrators, and Healthcare Systems

Reasons and Results of NO Predilation Before TAVR: How to Improve Outcomes and SIMPLIFY Your Life

Yes, Clearly!

Clopidogrel Prescription Filling Delays and Cardiovascular Outcomes in a Pharmacy System Integrating Inpatient and Outpatient Care

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content